Subscribe to Newsletter

Advanced Medicine

Manufacture Advanced Medicine

In Support of the Supply Chain

| Fiona Withey | 7 min read

From automation to integration, there is huge room for improvement in supply chain management systems for cell and gene therapies

Discovery & Development Drug Delivery

At First Sight

| Jamie Irvine | 13 min read

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Manufacture Advanced Medicine

Open or Closed?

| Krishnendu Khan | 5 min read

How to find the right balance in cell therapy manufacturing.

Manufacture Advanced Medicine

Interviewing Paul Donohoue: A Guiding RNA-DNA Light for CRISPR

| Stephanie Vine | 12 min read

The story of how Caribou Biosciences developed a hybrid RNA-DNA guide to increase Cas9 specificity.

Business & Regulation Profession

Interviews To Inspire

| Jamie Irvine

Our roundup of some of our thoughtful and inspiring video interviews and roundtables from the past year.

Business & Regulation Profession

Canadian Careers in Cell and Gene

| Stephanie Vine | 4 min read

Exploring the gaps and opportunities in Canada’s cell and gene workforce.

Manufacture Advanced Medicine

Notes, Quotes, and Anecdotes: Words of Wisdom from 2023

| Rob Coker | 5 min read

A selection of some of the most poignant words spoken by interviewees this year

Manufacture Advanced Medicine

Got You Covered

| Stephanie Vine | 3 min read

From flu vaccines, to gene editing, to antibody drug conjugates, and women’s careers; we look back on our 2023 magazine covers.

Manufacture Advanced Medicine

Format and Function: Optimizing Gene Therapy Manufacturing Workflow

| Elpidia Gamez | 4 min read

Gene therapy has the potential to transform lives, but promising treatments for a wide range of diseases require optimal cell culture media solutions

Business & Regulation Quality & Compliance

The FDA Investigates T-Cell Malignancies in CAR-T Therapy

| Jamie Irvine | 4 min read

The details and reactions behind a recent FDA investigation into the cancer-risk of CAR-T therapies

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine